Basel Medical Group Ltd (BMGL) stock
Close on Nov 13, 2026Market cap $743.59KP/E –Yield –
Basel Medical statistics
51 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- –
Valuation ratiosIndustry
Enterprise valuationIndustry
- EV / Sales
- 0.73
- –
Share statisticsIndustry
- Shares Change (YoY)
- -91.6%
- –
Short sellingIndustry
- Short Interest
- 107,869
- –
- Short Interest Change
- 731.6%
- –
- Days to Cover
- 1.00
- –
Stock price statisticsIndustry
- Price Change (1 Week)
- -91.1%
- –
- Price Change (1 Month)
- -88.0%
- –
- Price Change (3 Months)
- -91.0%
- –
- Price Change (6 Months)
- -94.0%
- –
- Price Change (YTD)
- -92.0%
- –
- Price Change (1 Year)
- -97.2%
- –
- Average Volume (10 Days)
- 3M
- –
- Average Volume (20 Days)
- 2M
- –
- Average Volume (90 Days)
- 1M
- –
- Relative Volume
- 0.61
- –
- Relative Strength Index (14)
- 18.3
- –
- Volatility (1 Year)
- 161.2%
- –
MarginsIndustry
- Pretax Margin
- -7.60%
- –
- FCF Margin
- -5.37%
- –
Returns on capitalIndustry
- Return on Assets (ROA)
- -4.10%
- –
Financial positionIndustry
- Current Ratio
- 1.23
- –
- Quick Ratio
- 1.10
- –
GrowthIndustry
- Revenue Growth (YoY)
- 45.2%
- –
EfficiencyIndustry
- Asset Turnover
- 0.90
- –
- Revenue Per Employee
- 202.99K SGD
- –
- Profits Per Employee
- -9.23K SGD
- –
- Employee Count
- 81
- –
Income statement (TTM)Industry
- Pretax Income
- -1.25M SGD
- –
Balance sheetIndustry
- Net Cash (Debt)
- -11.52M SGD
- –
- Net Cash Per Share
- -7.28 SGD
- –
- Working Capital
- 2.27M SGD
- –
Cash flow (TTM)Industry
- Capital Expenditures
- -248.23K SGD
- –
- FCF Per Share
- -0.56 SGD
- –
Dividends and yieldsIndustry
- Earnings Yield
- -78.5%
- –
- FCF Yield
- -92.7%
- –
Taxes and interestIndustry
- Interest Expense
- 459.33K SGD
- –
- Income Tax
- 179.56K SGD
- –
Scores and fair valueIndustry
- Altman Z-Score
- 0.78
- –
- Piotroski F-Score
- 4
- –
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | BMGL | S&P 500 | Difference | BMGL per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -87.8% | -3.0% | −84.8 pts | ||
| 3 months | -89.8% | -2.8% | −87.0 pts | ||
| Year to date | -92.0% | +11.5% | −103.5 pts | ||
| 1 year | -96.9% | +13.5% | −110.4 pts |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M BMGL shares were sold short on Oct 30, 2026, up 731.6% from the previous report. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 56.3% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 107,869 | +731.6% | 1,433,048 | 1.0 |
| Oct 15, 2026 | 12,972 | +14.7% | 445,494 | 1.0 |
| Sep 30, 2026 | 11,310 | -92.9% | 57,193 | 1.0 |
| Sep 15, 2026 | 159,585 | +1917.0% | 3,135,507 | 1.0 |
| Aug 31, 2026 | 7,912 | -28.0% | 27,475 | 1.0 |
| Aug 14, 2026 | 10,995 | -29.8% | 8,508 | 1.3 |
| Jul 31, 2026 | 15,664 | -51.9% | 7,540 | 2.1 |
| Jul 15, 2026 | 32,559 | +157.1% | 70,687 | 1.0 |
| Jun 30, 2026 | 12,662 | -96.0% | 12,536 | 1.0 |
| Jun 15, 2026 | 314,368 | +1768.6% | 2,921,328 | 1.0 |
| May 29, 2026 | 16,824 | -31.5% | 11,342 | 1.5 |
| May 15, 2026 | 24,576 | -77.7% | 31,239 | 1.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?